作者: Paul A. J. M. de Bont , Berber M. van der Vleugel , David P. G. van den Berg , Carlijn de Roos , Joran Lokkerbol
DOI: 10.1080/20008198.2018.1565032
关键词: Psychosis 、 Coste efectividad 、 Quality-adjusted life year 、 Economic benefits 、 In patient 、 Cost effectiveness 、 Posttraumatic stress 、 Psychiatry 、 Prolonged exposure 、 Medicine
摘要: Background: Co-occurrence of posttraumatic stress disorder (PTSD) in psychosis (estimated as 12%) raises personal suffering and societal costs. Health–economic studies on PTSD treatments patient...